QuantumPharm, Inc. (HK:2228) has released an update.
QuantumPharm Inc. has scheduled a board meeting for August 28, 2024, to discuss and potentially approve the interim financial results for the first half of the year ending June 30, 2024, and to consider the declaration of any dividends. The meeting will be a significant event for stakeholders, as decisions on company profits and future dividends will be made. The company, headquartered in the Cayman Islands and listed under stock code 2228, emphasizes the importance of this gathering for its directors and investors.
For further insights into HK:2228 stock, check out TipRanks’ Stock Analysis page.